Article
A simplified flow cytometric assay identifies children with acute lymphoblastic leukemia who have a superior clinical outcome.
Blood - 1 Jul 2006
Coustan-Smith Elaine, Ribeiro Raul C, Stow Patricia, Zhou Yinmei, Pui Ching-Hon, Rivera Gaston K, Pedrosa Francisco, Campana Dario
Abstract excerpt
Bone marrow normal lymphoid progenitors (CD19+, CD10+, and/or CD34+) are exquisitely sensitive to corticosteroids and other antileukemic drugs. We hypothesized that, in patients with B-lineage acute lymphoblastic leukemia (ALL), cells with this phenotype detected early in treatment should be leukemic rather than normal. We therefore developed a simple and inexpensive flow cytometric assay for such cells and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
